Fang Wu

2 clinical trials · Sponsor

Record	Firm	Date
ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC (NCT05198154)	Fang Wu	2022-01-24
The Effectiveness and Safety of SBRT in the Treatment of Patients With MPLC After Surgery (SMILE) (NCT05113017)	Fang Wu	2021-07-01

Every clearance here is in the API, with alerts when new ones post.